Delivery Order SPE2DB20D1051-SPE2DB24FD7GJ
Award Date
3/7/24
Potential Completion Date
3/8/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $13,055.53 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide XIFAXAN 550 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $22,097.29 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of XIFAXAN 550 mg tablets, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a potential value of up to $999,999,999.00 and runs...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,040.98, is for the delivery of XIFAXAN 550 mg tablets to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
The Defense Logistics Agency (DLA) awarded a $39,961.11 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of XIFAXAN 550 MG tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
The Defense Logistics Agency awarded a $6,855.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XIFAXAN 550 MG TABLET UD 60S. This delivery order contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The delivery order is issued under an indefinite delivery contract with a potential value of $999,999,999.00 and a...
This is a $11,119.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of the drug XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of April 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product XIFAXAN 550 mg tablets. The contract has a ceiling value of $82,211.95 and an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $13,569.08 for the supply of XIFAXAN 550 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has also received a separate indefinite delivery contract (IDC) from DLA, valued at...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XIFAXAN 550 mg tablets. The contract, valued at $26,667.99, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $8,072.23 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp will provide the drug product XIFAXAN 550 MG TABLET 60S to support military treatment programs and facilities. This delivery order is part of a larger indefinite...